Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,849.00
-251.00 (-11.95%)
At close: Mar 27, 2026
Market Cap17.15B +80.6%
Revenue (ttm)1.00B
Net Income-13.37B
EPS-1,637.42
Shares Out9.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume60,117
Average Volume21,385
Open2,100.00
Previous Close2,100.00
Day's Range1,785.00 - 2,100.00
52-Week Range714.00 - 3,300.00
Beta-0.12
RSI54.87
Earnings Daten/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops therapeutic drugs for non-alcoholic liver disease treatment and the anticancer field. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements